Record Information |
---|
Version | 1.0 |
---|
Created at | 2021-06-20 19:53:54 UTC |
---|
Updated at | 2021-06-30 00:08:41 UTC |
---|
NP-MRD ID | NP0036826 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | clathric acid |
---|
Provided By | JEOL Database |
---|
Description | Rel-Clathric Acid, also known as rel-clathrate, belongs to the class of organic compounds known as diterpenoids. These are terpene compounds formed by four isoprene units. clathric acid is found in Clathria compressa. It was first documented in 2021 (PMID: 34130335). Based on a literature review a significant number of articles have been published on Rel-Clathric Acid (PMID: 34130300) (PMID: 34130299) (PMID: 34130288) (PMID: 34130270). |
---|
Structure | [H]OC(=O)C([H])([H])[C@@]1([H])C(=C([H])[H])C([H])([H])C([H])([H])[C@@]2([H])[C@@](\C([H])=C(/[H])C([H])=C(C([H])([H])[H])C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H] InChI=1S/C21H32O2/c1-15(2)8-6-11-20(4)12-7-13-21(5)17(14-19(22)23)16(3)9-10-18(20)21/h6,8,11,17-18H,3,7,9-10,12-14H2,1-2,4-5H3,(H,22,23)/b11-6+/t17-,18-,20+,21+/m0/s1 |
---|
Synonyms | Value | Source |
---|
Rel-clathrate | Generator |
|
---|
Chemical Formula | C21H32O2 |
---|
Average Mass | 316.4850 Da |
---|
Monoisotopic Mass | 316.24023 Da |
---|
IUPAC Name | 2-[(1S,4aS,5S,8aR)-5,8a-dimethyl-2-methylidene-5-[(1E)-4-methylpenta-1,3-dien-1-yl]-decahydronaphthalen-1-yl]acetic acid |
---|
Traditional Name | clathric acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H]OC(=O)C([H])([H])[C@@]1([H])C(=C([H])[H])C([H])([H])C([H])([H])[C@@]2([H])[C@@](\C([H])=C(/[H])C([H])=C(C([H])([H])[H])C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H] |
---|
InChI Identifier | InChI=1S/C21H32O2/c1-15(2)8-6-11-20(4)12-7-13-21(5)17(14-19(22)23)16(3)9-10-18(20)21/h6,8,11,17-18H,3,7,9-10,12-14H2,1-2,4-5H3,(H,22,23)/b11-6+/t17-,18-,20+,21+/m0/s1 |
---|
InChI Key | RIZUAODWKFVFDS-HDASRLSZSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 400 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Species Name | Source | Reference |
---|
Clathria compressa | JEOL database | - Gupta, P., et al, J. Nat. Prod. 75, 1223 (2012)
|
|
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as diterpenoids. These are terpene compounds formed by four isoprene units. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Prenol lipids |
---|
Sub Class | Diterpenoids |
---|
Direct Parent | Diterpenoids |
---|
Alternative Parents | |
---|
Substituents | - Diterpenoid
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Li N, Yamamoto G, Fuji H, Kisseleva T: Interleukin-17 in Liver Disease Pathogenesis. Semin Liver Dis. 2021 Jun 15. doi: 10.1055/s-0041-1730926. [PubMed:34130335 ]
- Vanneste BGL, Van Limbergen EJ, Marcelissen TA, van Roermund JGH, Lutgens LC, Arnoldussen CWKP, Lambin P, Oelke M: Development of a Management Algorithm for Acute and Chronic Radiation Urethritis and Cystitis. Urol Int. 2021 Jun 15:1-12. doi: 10.1159/000515716. [PubMed:34130300 ]
- Zhao J, Yang T, Qiao W, Ye Y, Zhang J, Luo Q: Human Neutrophil Elastase Mediates MUC5AC Hypersecretion via the Tumour Necrosis Factor-alpha Converting Enzyme-Epidermal Growth Factor Receptor Signalling Pathway in vivo. ORL J Otorhinolaryngol Relat Spec. 2021 Jun 15:1-9. doi: 10.1159/000509982. [PubMed:34130299 ]
- Pan B, Zhang H, Hong Y, Ma M, Wan X, Cao C: Indoleamine-2,3-Dioxygenase Activates Wnt/beta-Catenin Inducing Kidney Fibrosis after Acute Kidney Injury. Gerontology. 2021 Jun 15:1-9. doi: 10.1159/000515041. [PubMed:34130288 ]
- Jiang Y, Zhang Y, Cao M, Li J, Wu M, Zhang H, Zheng S, Liu H, Yang M: Combining 'grafting to' and 'grafting from' to synthesize comb-like NCC-g-PLA as a macromolecular modifying agent of PLA. Nanotechnology. 2021 Jul 2;32(38). doi: 10.1088/1361-6528/ac0b63. [PubMed:34130270 ]
- Gupta, P., et al. (2012). Gupta, P., et al, J. Nat. Prod. 75, 1223 (2012). J. Nat. Prod..
|
---|